CIK: 1733272 - Address: C/O Bioxcel Therapeutics, Inc., 555 Long Wharf Drive, 12Th Floor, New Haven, CT 06511
17 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
4/8/24 19:30
3/14/24
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScM.dm00.00032813D
4/8/24 19:30
4/4/24
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScS.d-32.640-1-813D
12/18/23 16:57
12/14/23
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScM.d00.0001511D
9/18/23 16:49
9/14/23
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScM.d00.0001511D
6/16/23 18:44
6/14/23
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScM.d00.0001510D
3/16/23 18:01
3/14/23
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScM.d00.0002289D
3/16/23 18:01
3/15/23
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScS.d-1919.690-1-99D
1/24/23 20:08
1/20/23
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScS-1,50030.000-50-868D
3/17/21 17:00
3/15/21
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScS-72848.500-15-2058D
2/18/21 16:56
2/16/21
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScS-86557.680-15-1773D
1/27/21 16:25
1/25/21
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScM.d60.41000152088D
1/27/21 16:25
1/25/21
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScS.d-72648.390-15-1588D
2/19/20 17:22
2/14/20
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScM.d330.410008095388D
8/14/19 16:15
8/13/19
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScP578.67073548D
12/6/18 06:04
12/3/18
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScP.m55.2101952D
11/30/18 17:35
11/30/18
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScP25.2000901D
11/30/18 14:31
11/29/18
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScP35.0201New1D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact